Covid-19 slokt aandacht farma-industrie op, ten koste van andere dreigingen

Writing for the Dutch network NOS, Rinke van den Brink reports on the key findings of the 2021 Access to Medicine Index focusing on the ill-preparedness of the pharma industry for the COVID-19 pandemic.

Health experts have long warned about the global risks certain highly infectious pathogens pose. Rinke van den Brink explores through the results of the 2021 Index whether the world is ready for the next pandemic.

In assessing the progress of the pharma industry in broadening access to medicine, the article ascertains that low-income countries remain overlooked, facing a series of product delivery issues, ranging from insufficient regulation to limited licences and equitable pricing strategies. The domination of wealthy nations in securing access to COVID-19 vaccines only exacerbates the disparities.

Read the full article here.